Pay in 4 interest-free payments of $5.63 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
In This Article: Goals of Injection Treatments Subacromial injections have some combination of the following goals: Manage pain, swelling, and inflammation Facilitate participation in physical therapy and exercise Improve range of motion in the shoulder Improve healing in the injured muscles and tendons Through these potential benefits, the injections aim to help the patient better tolerate daily activities and improve the quality of life
BPC-157 / TB-500 is a precision co-lyophilized research blend combining two well-characterized peptides in a fixed 1:1 ratio, supplied exclusively for laboratory and preclinical research applications
Cognitive Decline and Neurodegenerative Conditions Cognitive decline and neurodegenerative conditions show substantial preclinical evidence across multiple pathologies: Stroke models: BPC-157 given during reperfusion counteracted neuronal damage and produced full functional recovery in spatial memory, motor coordination, and balance tests Parkinsons models: MPTP-induced models showed reduced motor symptoms (tremor, rigidity, akinesia), protection of nigrostriatal dopaminergic neurons, and near-complete prevention of mortality Multiple sclerosis models: Cuprizone-induced demyelination resulted in significantly less brain damage and reduced clinical abnormalities when BPC-157 was given in drinking water or intragastrically Traumatic brain injury: Falling weight model studies demonstrated reduced hemorrhage, decreased brain lacerations and edema, and improved early outcomes These diverse models share common mechanisms
Week 3 to 4: Texture improvements
